Figure 5

Monitoring clinical remission using a ctDNA molecular signature. Each panel shows patient-specific VAFs across various timepoints. In total there were 17 patients that had both molecular and clinical remission. A representative 4 patients are shown below. The remaining 13 patients are shown in Supplementary Fig. 2.